Skip to main content
Log in

Evaluating prostate cancer bone metastasis using accelerated whole-body isotropic 3D T1-weighted Dixon MRI with compressed SENSE: a feasibility study

  • Magnetic Resonance
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

The study aimed to assess the efficiency of whole-body high-resolution compressed sensing-sensitivity encoding isotropic T1-Weighted Dixon (CSI-T1W-Dixon) scans in evaluating bone metastasis.

Methods

Forty-five high-risk prostate cancer patients with bone metastases were enrolled prospectively and underwent whole-body MRI sequences, which included the following: pre- and post-contrast CSI-T1W-Dixon and conventional multi-planar T1-Weighted Dixon (CMP-T1W-Dixon) (coronal, sagittal, and axial scans), short tau inversion recovery (STIR), and DWI. Comparison between the CMP-T1W-Dixon and CSI-T1W-Dixon images was done for the subjective image quality, the quantitative contrast-to-noise ratio (CNR), and signal-to-noise ratio (SNR). Furthermore, the diagnostic performance based on per-lesion and per-patient basis utilizing non-contrast T1-weighted (T1)/T1+ contrasted T1-weighted (T1C)/T1 + T1C + STIR + DWI sequences was compared between the CSI-T1W-Dixon and CMP-T1W-Dixon methods using reference standards (combining biopsy data and 6-month imaging follow-up).

Result

The CSI-T1W-Dixon images produced fewer image artifacts in the axial and coronal planes compared to the CMP-T1W-Dixon images. Also, the CSI-T1W-Dixon images provided better a CNR in fat-only images of all three planes and water-only images of the axial plane (p < 0.05). The CSI-T1W-Dixon showed a higher sensitivity than the CMP-T1W-Dixon techniques in analyzing T1-only images on a per-lesion basis (82.7% vs. 53.8% for sensitivity, p = 0.03). On a per-patient basis, no difference was found in the diagnostic capacity between the CSI-T1W-Dixon and CMP-T1W-Dixon sequences either alone or in combinations (p = 0.57–1).

Conclusion

High-resolution CSI-T1W-Dixon with higher image quality and diagnostic capacity can replace the CMP-T1W-Dixon method in evaluating bone metastasis in clinical practice.

Key Points

• Compressed sensing isotropic acquisition for 3D T1-weighted Dixon images can improve the image quality with fewer artifacts compared to the anisotropic multiplanar acquisition.

• Compressed sensing isotropic acquisition can save 67% of scanning time compared to anisotropic multiplanar acquisition.

• Compressed sensing isotropic 3D T1-weighted Dixon images can offer better diagnostic performance with higher sensitivity compared to anisotropic multiplanar images.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AUC:

Area under the operating characteristic curve

CMP:

Conventional multiplanar

CMP-T1W-Dixon:

Conventional multi-planar T1-Weighted Dixon

CNR:

Contrast-to-noise ratio

Compressed SENSE:

Compressed sensing-sensitivity encoding

CSI:

Compressed SENSE isotropic

CSI-T1W-Dixon:

Compressed SENSE isotropic T1-Weighted Dixon

CT:

Computed tomography

DWI:

Diffusion-weighted imaging

F:

Fat-only

IP:

In-phase

MRI:

Magnetic resonance imaging

OP:

Out-of-phase

PET:

Positron emission tomography

PI:

Parallel imaging

ROC:

Receiver operating characteristic

ROI:

Region of interest

SD:

Standard deviation

SI:

Signal intensity

SNR:

Signal-to-noise ratio

STIR:

Short tau inversion recovery

T1:

Noncontrast T1-weighted

T1C:

Contrast T1-weighted

T1W:

T1-Weighted

W:

Water-only

References

  1. Morone M, Bali MA, Tunariu N et al (2017) Whole-body MRI: current applications in oncology. AJR Am J Roentgenol 209:W336–W349

    Article  PubMed  Google Scholar 

  2. Petralia G, Padhani AR, Pricolo P et al (2019) Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses. Radiol Med 124:218–233

    Article  PubMed  Google Scholar 

  3. Shen G, Deng H, Hu S, Jia Z (2014) Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol 43:1503–1513

    Article  PubMed  Google Scholar 

  4. Ma J, Costelloe CM, Madewell JE et al (2009) Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases. J Magn Reson Imaging 29:1154–1162

    Article  PubMed  Google Scholar 

  5. Costelloe CM, Madewell JE, Kundra V, Harrell RK, Bassett RL Jr, Ma J (2013) Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence. Magn Reson Imaging 31:669–675

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lecouvet FE, Pasoglou V, Van Nieuwenhove S et al (2020) Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer. Eur Radiol 30:3083–3093

    Article  PubMed  Google Scholar 

  7. Bray TJP, Singh S, Latifoltojar A et al (2017) Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study. PLoS One 12:e0180562

    Article  PubMed  PubMed Central  Google Scholar 

  8. Goo HW (2015) Whole-body MRI in children: current imaging techniques and clinical applications. Korean J Radiol 16:973–985

    Article  PubMed  PubMed Central  Google Scholar 

  9. Costelloe CM, Kundra V, Ma J et al (2012) Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study. J Magn Reson Imaging 35:399–408

    Article  PubMed  Google Scholar 

  10. Westerland O, Sivarasan N, Natas S et al (2018) Added value of contrast-enhanced T1-weighted and diffusion-weighted sequences for characterization of incidental findings on whole body magnetic resonance imaging in plasma-cell disorders. Clin Lymphoma Myeloma Leuk 18:822–828

    Article  PubMed  Google Scholar 

  11. Nam JG, Lee JM, Lee SM et al (2019) High acceleration three-dimensional T1-weighted dual echo dixon hepatobiliary phase imaging using compressed sensing-sensitivity encoding: comparison of image quality and solid lesion detectability with the standard T1-weighted Sequence. Korean J Radiol 20:438–448

    Article  PubMed  PubMed Central  Google Scholar 

  12. Vranic JE, Cross NM, Wang Y, Hippe DS, de Weerdt E, Mossa-Basha M (2019) Compressed Sensing-Sensitivity Encoding (CS-SENSE) Accelerated brain imaging: reduced scan time without reduced image quality. AJNR Am J Neuroradiol 40:92–98

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Liang D, Liu B, Wang J, Ying L (2009) Accelerating SENSE using compressed sensing. Magn Reson Med 62:1574–1584

    Article  PubMed  Google Scholar 

  14. Larbi A, Omoumi P, Pasoglou V et al (2019) Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences. Eur Radiol 29:4503–4513

    Article  PubMed  Google Scholar 

  15. Pasoglou V, Michoux N, Peeters F et al (2015) Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease. Radiology 275:155–166

    Article  PubMed  Google Scholar 

  16. Papageorgiou I, Dvorak J, Cosma I, Pfeil A, Teichgraeber U, Malich A (2020) Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer. Clin Transl Oncol 22:1321–1328

    Article  CAS  PubMed  Google Scholar 

  17. Zeilinger MG, Wiesmuller M, Forman C et al (2021) 3D Dixon water-fat LGE imaging with image navigator and compressed sensing in cardiac MRI. Eur Radiol 31:3951–3961

    Article  PubMed  Google Scholar 

  18. Zech CJ, Herrmann KA, Huber A et al (2004) High-resolution MR-imaging of the liver with T2-weighted sequences using integrated parallel imaging: comparison of prospective motion correction and respiratory triggering. J Magn Reson Imaging 20:443–450

    Article  PubMed  Google Scholar 

  19. Nael K, Ruehm SG, Michaely HJ et al (2006) High spatial-resolution CE-MRA of the carotid circulation with parallel imaging: comparison of image quality between 2 different acceleration factors at 3.0 Tesla. Invest Radiol 41:391–399

    Article  PubMed  Google Scholar 

  20. Bratke G, Rau R, Weiss K et al (2019) Accelerated MRI of the Lumbar Spine Using Compressed Sensing: Quality and Efficiency. J Magn Reson Imaging 49:e164–e175

    Article  PubMed  Google Scholar 

  21. Lecouvet FE, Simon M, Tombal B, Jamart J, Vande Berg BC, Simoni P (2010) Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa). Eur Radiol 20:2973–2982

    Article  CAS  PubMed  Google Scholar 

  22. Costelloe CM, Chuang HH, Madewell JE, Ueno NT (2010) Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST. J Cancer 1:80–92

    Article  PubMed  PubMed Central  Google Scholar 

  23. Feng L, Benkert T, Block KT, Sodickson DK, Otazo R, Chandarana H (2017) Compressed sensing for body MRI. J Magn Reson Imaging 45:966–987

    Article  PubMed  Google Scholar 

  24. Stecco A, Trisoglio A, Soligo E, Berardo S, Sukhovei L, Carriero A (2018) Whole-body MRI with diffusion-weighted imaging in bone metastases: a narrative review. Diagnostics (Basel) 8:45

    Article  CAS  PubMed  Google Scholar 

  25. Carlbom L, Caballero-Corbalan J, Granberg D, Sorensen J, Eriksson B, Ahlstrom H (2017) Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors. Ups J Med Sci 122:43–50

    Article  PubMed  Google Scholar 

  26. Schmidt GP, Reiser MF, Baur-Melnyk A (2009) Whole-body MRI for the staging and follow-up of patients with metastasis. Eur J Radiol 70:393–400

    Article  PubMed  Google Scholar 

  27. Latifoltojar A, Duncan MKJ, Klusmann M et al (2020) Whole body 3.0 T magnetic resonance imaging in lymphomas: comparison of different sequence combinations for staging hodgkin’s and diffuse large B cell lymphomas. J Pers Med 10:284

    Article  PubMed  PubMed Central  Google Scholar 

  28. Del Vescovo R, Frauenfelder G, Giurazza F et al (2014) Role of whole-body diffusion-weighted MRI in detecting bone metastasis. Radiol Med 119:758–766

    Article  PubMed  Google Scholar 

  29. Jambor I, Kuisma A, Ramadan S et al (2016) Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Acta Oncol 55:59–67

    Article  PubMed  Google Scholar 

  30. Lecouvet FE, El Mouedden J, Collette L et al (2012) Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 62:68–75

    Article  PubMed  Google Scholar 

  31. Gutzeit A, Doert A, Froehlich JM et al (2010) Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 39:333–343

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Yong Zhang for his assistance in image analysis.

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bing Ming.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Zhenhong Liao.

Conflict of interest

One of the authors of this manuscript (Xiaoyong Zhang) was an employee of Philips Medical Systems International. The remaining authors declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

One of the authors (Zhenhong Liao) has significant statistical expertise.

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was obtained from all subjects (patients) in this study.

Ethical approval

Institutional Review Board approval was obtained.

Study subjects or cohorts overlap

Whole-body compressed sensing isotropic T1-weighted Dixon has not been previously reported.

Methodology

• prospective

• diagnostic study

• performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

ESM 1

(PDF 3.21 MB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liao, Z., Liu, G., Ming, B. et al. Evaluating prostate cancer bone metastasis using accelerated whole-body isotropic 3D T1-weighted Dixon MRI with compressed SENSE: a feasibility study. Eur Radiol 33, 1719–1728 (2023). https://doi.org/10.1007/s00330-022-09181-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-022-09181-9

Keywords

Navigation